U.S., Sept. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07158099) titled 'Bioequivalence Study of WP205 in Healthy Subjects' on Aug. 27.
Brief Summary: This study is a single-center, randomized, open-label, two-period, two-sequence, single-dose, crossover bioequivalence trial conducted under fasting conditions in healthy adult volunteers. Participants will be randomized into two sequences (A and B). Each participant will receive a single intramuscular dose of the test or reference formulation according to the assigned sequence, with an adequate washout period between dosing. The primary objective of the study is to evaluate the bioequivalence of the two formulations.
Study Start Date: Sept. 15
Study Typ...